Griffiths P, Quigley E, Vandam L, Mounteney J. The Challenge of Responding to a More Globally Joined-up, Dynamic, and Innovative Drug Market: Reflections from the EMCDDA´s 2018 Analysis of the European Drug Situation. Dusunen Adam J Psychiatr Neurol Sci. 2018 ;31(3):231-237. doi: 10.5350/DAJPN20183103001.
Griffiths P, Quigley E, Vandam L, Mounteney J. The Challenge of Responding to a More Globally Joined-up, Dynamic, and Innovative Drug Market: Reflections from the EMCDDA´s 2018 Analysis of the European Drug Situation. Dusunen Adam J Psychiatr Neurol Sci. 2018;31(3):231-237. doi: 10.5350/DAJPN20183103001
Griffiths, P., Quigley, E., Vandam, L., & Mounteney, J. (2018). The Challenge of Responding to a More Globally Joined-up, Dynamic, and Innovative Drug Market: Reflections from the EMCDDA´s 2018 Analysis of the European Drug Situation. Dusunen Adam Journal of Psychiatry and Neurological Sciences, 31(3), 231-237. https://doi.org/10.5350/DAJPN20183103001
Griffiths, P., et al. "The Challenge of Responding to a More Globally Joined-up, Dynamic, and Innovative Drug Market: Reflections from the EMCDDA´s 2018 Analysis of the European Drug Situation." Dusunen Adam Journal of Psychiatry and Neurological Sciences, vol. 31, no. 3, 2018, pp. 231-237. https://doi.org/10.5350/DAJPN20183103001.
Griffiths, P., et al. 2018. "The Challenge of Responding to a More Globally Joined-up, Dynamic, and Innovative Drug Market: Reflections from the EMCDDA´s 2018 Analysis of the European Drug Situation." Dusunen Adam Journal of Psychiatry and Neurological Sciences 31, no. 3: 231-237. https://doi.org/10.5350/DAJPN20183103001.